NEW YORK (GenomeWeb News) – Quidel will receive about $1.9 million this year from its 2012 collaboration with Life Technologies to develop molecular assays, Quidel said in its Form 10-Q filed with the US Securities and Exchange Commission this week.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.